COVID-19 Infection and Outcomes at a Comprehensive Sickle Cell Center

por El Rassi, Fuad, Abouyabis, Abeer N., Fasano, Ross M., McLemore, Morgan L.
Publicado 2021

Extreme hyperbilirubinemia: An indicator of morbidity and mortality in sickle cell disease

por Haydek, John Paul, Taborda, Cesar, Shah, Rushikesh, Reshamwala, Preeti A, McLemore, Morgan L, Rassi, Fuad El, Chawla, Saurabh
Publicado 2019

Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia

por Jillella, Anand P., Arellano, Martha L., Gaddh, Manila, Langston, Amy A., Heffner, Leonard T., Winton, Elliott F., McLemore, Morgan L., Zhang, Chao, Caprara, Catherine R., Simon, Kathryn S., Bolds, Sheldon L., DeBragga, Stephanie, Karkhanis, Prachi, Krishnamurthy, Shruthi H., Tongol, Jose, El Geneidy, Mohamed M., Pati, Asim, Gerber, Jonathan M., Grunwald, Michael R., Cortes, Jorge, Bashey, Asad, Stuart, Robert K., Kota, Vamsi K.
Publicado 2021